Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Mestre - Venezia

4 clinical trials in Mestre - Venezia, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Mestre - Venezia at a glance
4
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Mestre - Venezia

Open in trial search

Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB

Study of Azacitidine and Drug Combination Before Stem Cell Transplantation in Patients with High-Risk Myelodysplastic Syndrome

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Fondazione Gimema Franco Mandelli Onlus

Graft versus host disease

Not yet recruiting

A study to evaluate the effectiveness of MC0518 (mesenchymal stromal cells) in adults with acute graft-versus-host disease that has not responded to steroids and ruxolitinib

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Mesenchymal Stromal Cells, Ex Vivo Cultured
  • Sponsor:Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia

Study on Pirfenidone for Preventing Lung Fibrosis in Patients with Acute Respiratory Distress Syndrome (ARDS)

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Pirfenidone
  • Sponsor:Ospedale San Raffaele S.r.l.

Other cities in Italy

The busiest research cities in the country

All 237 cities in Italy

Clinical research in Mestre - Venezia

What the registry says about research in the country

01 Hematology Research

Groundbreaking research focusing on myelodysplastic syndromes, specifically investigating innovative treatment combinations for high-risk cases. The studies explore the effectiveness of combining hypomethylating therapy with hematopoietic stem cell transplantation.

  • Treatment Optimization for High-Risk MDS
  • Stem Cell Transplantation Protocols
  • Bone Marrow Assessment Studies

These clinical trials aim to improve treatment outcomes for patients with varying levels of bone marrow blast percentages, potentially establishing new therapeutic standards in hematologic oncology.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.